메뉴 건너뛰기




Volumn 112, Issue 3, 2013, Pages 329-338

The soluble VEGF receptor 1 and 2 expression in cerebral spinal fluid as an indicator for leukemia central nervous system metastasis

Author keywords

Central nervous system leukemia; Cerebrospinal fluid; Serum; sVEGFR1; sVEGFR2

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

EID: 84885035067     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1066-x     Document Type: Article
Times cited : (19)

References (40)
  • 1
    • 0036984640 scopus 로고    scopus 로고
    • Role of angiogenesis in tumor growth and metastasis
    • 12516034 1:CAS:528:DC%2BD3sXlvFSqtg%3D%3D
    • Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15-18
    • (2002) Semin Oncol , vol.29 , pp. 15-18
    • Folkman, J.1
  • 2
    • 4143136640 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: Basic science and clinical progress
    • 15294883 10.1210/er.2003-0027 1:CAS:528:DC%2BD2cXns1Ght74%3D
    • Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611
    • (2004) Endocr Rev , vol.25 , pp. 581-611
    • Ferrara, N.1
  • 3
    • 0035009960 scopus 로고    scopus 로고
    • Increased bone marrow vascularization in patients with acute myeloid leukaemia: A possible role for vascular endothelial growth factor
    • 11380392 10.1046/j.1365-2141.2001.02722.x
    • De Bont ES, Rosati S, Jacobs S, Kamps WA, Vellenga E (2001) Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. Br J Haematol 113:296-304
    • (2001) Br J Haematol , vol.113 , pp. 296-304
    • De Bont, E.S.1    Rosati, S.2    Jacobs, S.3    Kamps, W.A.4    Vellenga, E.5
  • 4
    • 0036841072 scopus 로고    scopus 로고
    • Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes
    • 12404286 10.1002/cncr.10900
    • Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'brien S, Keating MJ, Albitar M (2002) Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer 95:1923-1930
    • (2002) Cancer , vol.95 , pp. 1923-1930
    • Aguayo, A.1    Kantarjian, H.M.2    Estey, E.H.3    Giles, F.J.4    Verstovsek, S.5    Manshouri, T.6    Gidel, C.7    O'Brien, S.8    Keating, M.J.9    Albitar, M.10
  • 5
    • 0035885932 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors
    • 11535528 10.1182/blood.V98.6.1904 1:CAS:528:DC%2BD3MXntFWgt7g%3D
    • Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS (2001) Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98:1904-1913
    • (2001) Blood , vol.98 , pp. 1904-1913
    • Masood, R.1    Cai, J.2    Zheng, T.3    Smith, D.L.4    Hinton, D.R.5    Gill, P.S.6
  • 6
    • 0034925637 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells
    • 11306513 1:CAS:528:DC%2BD3MXis1ehsbk%3D
    • Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H (2001) Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 12:129-135
    • (2001) Cell Growth Differ , vol.12 , pp. 129-135
    • Price, D.J.1    Miralem, T.2    Jiang, S.3    Steinberg, R.4    Avraham, H.5
  • 8
    • 33846978760 scopus 로고    scopus 로고
    • The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma
    • 17150246 10.1016/j.ygyno.2006.09.031 1:CAS:528:DC%2BD2sXitFOgsL0%3D
    • Mylona E, Alexandrou P, Giannopoulou I, Liapis G, Sofia M, Keramopoulos A, Nakopoulou L (2007) The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma. Gynecol Oncol 104:557-563
    • (2007) Gynecol Oncol , vol.104 , pp. 557-563
    • Mylona, E.1    Alexandrou, P.2    Giannopoulou, I.3    Liapis, G.4    Sofia, M.5    Keramopoulos, A.6    Nakopoulou, L.7
  • 9
    • 33744812156 scopus 로고    scopus 로고
    • Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage i non-small-cell lung cancer
    • 16697074 10.1016/j.lungcan.2006.02.009
    • Seto T, Higashiyama M, Funai H, Imamura F, Uematsu K, Seki N, Eguchi K, Yamanaka T, Ichinose Y (2006) Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. Lung Cancer 53:91-96
    • (2006) Lung Cancer , vol.53 , pp. 91-96
    • Seto, T.1    Higashiyama, M.2    Funai, H.3    Imamura, F.4    Uematsu, K.5    Seki, N.6    Eguchi, K.7    Yamanaka, T.8    Ichinose, Y.9
  • 10
    • 0037699954 scopus 로고    scopus 로고
    • The biology of VEGF and its receptors
    • 12778165 10.1038/nm0603-669 1:CAS:528:DC%2BD3sXktFOnur4%3D
    • Ferrara N, Gerber HP, Lecouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676
    • (2003) Nat Med , vol.9 , pp. 669-676
    • Ferrara, N.1    Gerber, H.P.2    Lecouter, J.3
  • 11
    • 33646107369 scopus 로고    scopus 로고
    • VEGF receptor signalling - In control of vascular function
    • 16633338 10.1038/nrm1911 1:CAS:528:DC%2BD28XjslSktrc%3D
    • Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7:359-371
    • (2006) Nat Rev Mol Cell Biol , vol.7 , pp. 359-371
    • Olsson, A.K.1    Dimberg, A.2    Kreuger, J.3    Claesson-Welsh, L.4
  • 12
    • 0034595635 scopus 로고    scopus 로고
    • Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
    • 10747927 10.1074/jbc.M000528200 1:CAS:528:DC%2BD3cXjvFCmsb0%3D
    • Rahimi N, Dayanir V, Lashkari K (2000) Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J Biol Chem 275:16986-16992
    • (2000) J Biol Chem , vol.275 , pp. 16986-16992
    • Rahimi, N.1    Dayanir, V.2    Lashkari, K.3
  • 13
    • 14644440555 scopus 로고    scopus 로고
    • Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
    • 15585754 10.1200/JCO.2005.06.081 1:CAS:528:DC%2BD2MXit1Gnsro%3D
    • Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027
    • (2005) J Clin Oncol , vol.23 , pp. 1011-1027
    • Hicklin, D.J.1    Ellis, L.M.2
  • 14
    • 30744436544 scopus 로고    scopus 로고
    • Neuroscience: A painful factor
    • 16355200 10.1038/438923a 1:CAS:528:DC%2BD2MXhtlSksr3E
    • Torsney C, Macdermott AB (2005) Neuroscience: a painful factor. Nature 438:923-925
    • (2005) Nature , vol.438 , pp. 923-925
    • Torsney, C.1    Macdermott, A.B.2
  • 15
    • 1942466613 scopus 로고    scopus 로고
    • Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes
    • 15112269 10.1002/cncr.20187 1:CAS:528:DC%2BD2cXkt1Sgs7Y%3D
    • Hu Q, Dey AL, Yang Y, Shen Y, Jilani IB, Estey EH, Kantarjian HM, Giles FJ, Albitar M (2004) Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 100:1884-1891
    • (2004) Cancer , vol.100 , pp. 1884-1891
    • Hu, Q.1    Dey, A.L.2    Yang, Y.3    Shen, Y.4    Jilani, I.B.5    Estey, E.H.6    Kantarjian, H.M.7    Giles, F.J.8    Albitar, M.9
  • 16
    • 65249100178 scopus 로고    scopus 로고
    • A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap
    • 19352513 10.1371/journal.pone.0005108
    • Wu FT, Stefanini MO, Mac Gabhann F, Popel AS (2009) A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap. PLoS ONE 4:e5108
    • (2009) PLoS ONE , vol.4 , pp. 5108
    • Wu, F.T.1    Stefanini, M.O.2    Mac Gabhann, F.3    Popel, A.S.4
  • 17
    • 1542298941 scopus 로고    scopus 로고
    • In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment
    • 15010291 10.1016/j.yexmp.2003.10.010 1:CAS:528:DC%2BD2cXhvV2htbY%3D
    • Kou B, Li Y, Zhang L, Zhu G, Wang X, Xia J, Shi Y (2004) In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment. Exp Mol Pathol 76:129-137
    • (2004) Exp Mol Pathol , vol.76 , pp. 129-137
    • Kou, B.1    Li, Y.2    Zhang, L.3    Zhu, G.4    Wang, X.5    Xia, J.6    Shi, Y.7
  • 19
    • 0037215473 scopus 로고    scopus 로고
    • Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man
    • 12500095 10.1097/00004647-200301000-00010 1:CAS:528:DC%2BD38Xpslakt7c%3D
    • Scheufler KM, Drevs J, Van Velthoven V, Reusch P, Klisch J, Augustin HG, Zentner J, Marme D (2003) Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. J Cereb Blood Flow Metab 23:99-110
    • (2003) J Cereb Blood Flow Metab , vol.23 , pp. 99-110
    • Scheufler, K.M.1    Drevs, J.2    Van Velthoven, V.3    Reusch, P.4    Klisch, J.5    Augustin, H.G.6    Zentner, J.7    Marme, D.8
  • 20
    • 0036497957 scopus 로고    scopus 로고
    • Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer
    • 11857378 10.1002/ijc.10121 1:CAS:528:DC%2BD38Xht1WgsLo%3D
    • Toi M, Bando H, Ogawa T, Muta M, Hornig C, Weich HA (2002) Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer. Int J Cancer 98:14-18
    • (2002) Int J Cancer , vol.98 , pp. 14-18
    • Toi, M.1    Bando, H.2    Ogawa, T.3    Muta, M.4    Hornig, C.5    Weich, H.A.6
  • 21
    • 79952763833 scopus 로고    scopus 로고
    • Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients
    • 21219538 10.1111/j.1349-7006.2011.01860.x 1:CAS:528:DC%2BC3MXltFGjt7Y%3D
    • Kikuchi S, Obata Y, Yagyu K, Lin Y, Nakajima T, Kobayashi O, Kikuichi M, Ushijima R, Kurosawa M, Ueda J (2011) Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients. Cancer Sci 102:866-869
    • (2011) Cancer Sci , vol.102 , pp. 866-869
    • Kikuchi, S.1    Obata, Y.2    Yagyu, K.3    Lin, Y.4    Nakajima, T.5    Kobayashi, O.6    Kikuichi, M.7    Ushijima, R.8    Kurosawa, M.9    Ueda, J.10
  • 22
    • 77649180815 scopus 로고    scopus 로고
    • Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery
    • 19551437 10.1007/s00464-009-0575-3 1:STN:280:DC%2BC3c%2FmsVKmuw%3D%3D
    • Shantha Kumara HM, Cabot JC, Hoffman A, Luchtefeld M, Kalady MF, Hyman N, Feingold D, Baxter R, Whelan RL (2010) Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery. Surg Endosc 24:283-289
    • (2010) Surg Endosc , vol.24 , pp. 283-289
    • Shantha Kumara, H.M.1    Cabot, J.C.2    Hoffman, A.3    Luchtefeld, M.4    Kalady, M.F.5    Hyman, N.6    Feingold, D.7    Baxter, R.8    Whelan, R.L.9
  • 24
    • 84875379598 scopus 로고    scopus 로고
    • Expression and significance of vascular endothelial growth factor A and C in leukemia central nervous system metastasis
    • 10.1016/j.leukres.2012.10.008
    • Tang YT, Jiang F, Guo L, Si MY, Jiao XY (2012) Expression and significance of vascular endothelial growth factor A and C in leukemia central nervous system metastasis. Leuk Res. doi: 10.1016/j.leukres.2012.10.008
    • (2012) Leuk Res
    • Tang, Y.T.1    Jiang, F.2    Guo, L.3    Si, M.Y.4    Jiao, X.Y.5
  • 25
    • 77951961591 scopus 로고    scopus 로고
    • Mechanisms of intermittent hypoxia induced hypertension
    • 19818095 10.1111/j.1582-4934.2009.00929.x
    • Bosc LV, Resta T, Walker B, Kanagy NL (2010) Mechanisms of intermittent hypoxia induced hypertension. J Cell Mol Med 14:3-17
    • (2010) J Cell Mol Med , vol.14 , pp. 3-17
    • Bosc, L.V.1    Resta, T.2    Walker, B.3    Kanagy, N.L.4
  • 26
    • 34249318758 scopus 로고    scopus 로고
    • Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability
    • 17077813 10.1038/sj.jcbfm.9600420 1:CAS:528:DC%2BD2sXnt1Sltrk%3D
    • Kumai Y, Ooboshi H, Ibayashi S, Ishikawa E, Sugimori H, Kamouchi M, Kitazono T, Egashira K, Iida M (2007) Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability. J Cereb Blood Flow Metab 27:1152-1160
    • (2007) J Cereb Blood Flow Metab , vol.27 , pp. 1152-1160
    • Kumai, Y.1    Ooboshi, H.2    Ibayashi, S.3    Ishikawa, E.4    Sugimori, H.5    Kamouchi, M.6    Kitazono, T.7    Egashira, K.8    Iida, M.9
  • 27
    • 32044456959 scopus 로고    scopus 로고
    • Exercise increases soluble vascular endothelial growth factor receptor-1 (sFlt-1) in circulation of healthy volunteers
    • 16449946 1:CAS:528:DC%2BD28Xit1yltL0%3D
    • Bailey AP, Shparago M, Gu JW (2006) Exercise increases soluble vascular endothelial growth factor receptor-1 (sFlt-1) in circulation of healthy volunteers. Med Sci Monit 12:CR45-CR50
    • (2006) Med Sci Monit , vol.12
    • Bailey, A.P.1    Shparago, M.2    Gu, J.W.3
  • 28
    • 0022135739 scopus 로고
    • Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
    • 3862359 10.7326/0003-4819-103-4-620 1:STN:280:DyaL2MzgsFaitg%3D%3D
    • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620-625
    • (1985) Ann Intern Med , vol.103 , pp. 620-625
    • Bennett, J.M.1    Catovsky, D.2    Daniel, M.T.3    Flandrin, G.4    Galton, D.A.5    Gralnick, H.R.6    Sultan, C.7
  • 29
    • 0022452185 scopus 로고
    • Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment
    • 3528788 10.1002/mpo.2950140317 1:STN:280:DyaL28zhtVGjug%3D%3D
    • Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D'angio G (1986) Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 14:191-194
    • (1986) Med Pediatr Oncol , vol.14 , pp. 191-194
    • Mastrangelo, R.1    Poplack, D.2    Bleyer, A.3    Riccardi, R.4    Sather, H.5    D'Angio, G.6
  • 31
    • 0035676373 scopus 로고    scopus 로고
    • Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals-correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels
    • 11704886 10.1080/135502801753248123 1:CAS:528:DC%2BD38XjvVCntQ%3D%3D
    • Andersson LM, Hagberg L, Fuchs D, Svennerholm B, Gisslen M (2001) Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals-correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. J Neurovirol 7:542-547
    • (2001) J Neurovirol , vol.7 , pp. 542-547
    • Andersson, L.M.1    Hagberg, L.2    Fuchs, D.3    Svennerholm, B.4    Gisslen, M.5
  • 32
    • 80051709700 scopus 로고    scopus 로고
    • Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins
    • 21857898 10.1371/journal.pone.0020599 1:CAS:528:DC%2BC3MXhtFKmsLrJ
    • Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z (2011) Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS ONE 6:e20599
    • (2011) PLoS ONE , vol.6 , pp. 20599
    • Feng, S.1    Cen, J.2    Huang, Y.3    Shen, H.4    Yao, L.5    Wang, Y.6    Chen, Z.7
  • 33
    • 65549153701 scopus 로고    scopus 로고
    • Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells
    • 19276374 10.1158/0008-5472.CAN-08-2905 1:CAS:528:DC%2BD1MXjtFyqu7Y%3D
    • Rahimi N, Golde TE, Meyer RD (2009) Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells. Cancer Res 69:2607-2614
    • (2009) Cancer Res , vol.69 , pp. 2607-2614
    • Rahimi, N.1    Golde, T.E.2    Meyer, R.D.3
  • 34
    • 0030609013 scopus 로고    scopus 로고
    • Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
    • 9393770 1:CAS:528:DyaK2sXnslGqs7o%3D
    • Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marme D (1997) Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57:5421-5425
    • (1997) Cancer Res , vol.57 , pp. 5421-5425
    • Barleon, B.1    Siemeister, G.2    Martiny-Baron, G.3    Weindel, K.4    Herzog, C.5    Marme, D.6
  • 35
    • 10844238910 scopus 로고    scopus 로고
    • Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation
    • 15611243 1:CAS:528:DC%2BD2cXhtFaiur3P
    • Dikov MM, Ohm JE, Ray N, Tchekneva EE, Burlison J, Moghanaki D, Nadaf S, Carbone DP (2005) Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol 174:215-222
    • (2005) J Immunol , vol.174 , pp. 215-222
    • Dikov, M.M.1    Ohm, J.E.2    Ray, N.3    Tchekneva, E.E.4    Burlison, J.5    Moghanaki, D.6    Nadaf, S.7    Carbone, D.P.8
  • 36
    • 0036718433 scopus 로고    scopus 로고
    • Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients
    • 12231527
    • De Bont ES, Fidler V, Meeuwsen T, Scherpen F, Hahlen K, Kamps WA (2002) Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. Clin Cancer Res 8:2856-2861
    • (2002) Clin Cancer Res , vol.8 , pp. 2856-2861
    • De Bont, E.S.1    Fidler, V.2    Meeuwsen, T.3    Scherpen, F.4    Hahlen, K.5    Kamps, W.A.6
  • 38
    • 0032795396 scopus 로고    scopus 로고
    • Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA
    • 10410982 10.1016/S0022-1759(99)00065-4 1:CAS:528:DyaK1MXjt1Kmsb4%3D
    • Hornig C, Behn T, Bartsch W, Yayon A, Weich HA (1999) Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA. J Immunol Methods 226:169-177
    • (1999) J Immunol Methods , vol.226 , pp. 169-177
    • Hornig, C.1    Behn, T.2    Bartsch, W.3    Yayon, A.4    Weich, H.A.5
  • 39
    • 80053615559 scopus 로고    scopus 로고
    • Blood-brain barrier integrity and breast cancer metastasis to the brain
    • 21253507
    • Arshad F, Wang L, Sy C, Avraham S, Avraham HK (2010) Blood-brain barrier integrity and breast cancer metastasis to the brain. Patholog Res Int 2011:920509
    • (2010) Patholog Res Int , vol.2011 , pp. 920509
    • Arshad, F.1    Wang, L.2    Sy, C.3    Avraham, S.4    Avraham, H.K.5
  • 40
    • 79955105059 scopus 로고    scopus 로고
    • Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer
    • 21504321 10.1586/era.10.171 1:CAS:528:DC%2BC3MXkvF2isb4%3D
    • Yang F, Jin C, Jiang YJ, Li J, Di Y, Fu DL (2011) Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer. Expert Rev Anticancer Ther 11:541-549
    • (2011) Expert Rev Anticancer Ther , vol.11 , pp. 541-549
    • Yang, F.1    Jin, C.2    Jiang, Y.J.3    Li, J.4    Di, Y.5    Fu, D.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.